AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. PANW
3. SPY
4. MDT
5. AAPL
6. SPGI
7. USO
8. ENOV
9. NIO
10. AON

Go back to AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings
AbbVie (NYSE: ABBV) Delayed: 259.99 --0 (-0%)
Previous Close $259.99    52 Week High $68.12 
Open $259.99    52 Week Low $50.71 
Day High $259.99    P/E 56.40 
Day Low $259.99    EPS $4.61 
Volume 266